Advertisement
News
Advertisement

Mersana snaps up $27M fundraise

Tue, 07/31/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Cambridge-based Mersana Therapeutics Inc., which develops medicines aimed at cancer using a proprietary, biodegradable polymer it calls Fleximer, has raised $27 million in Series A1 funding led by new investor New Enterprise Associates (NEA).

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading